SARG was first found highly expressed in prostate cancer, its down-regulation induced epithelial to mesenchymal transition in epithelial prostate cancer cell line PC3 cells, suggesting that it may be a new EMT regulatory factor (8). The gene discussed is C1orf116; the disease is prostate cancer.